China National Medicines (SHSE:600511) COGS-to-Revenue : 0.93 (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is China National Medicines COGS-to-Revenue?

China National Medicines's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥11,270 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥12,122 Mil.

China National Medicines's COGS to Revenue for the three months ended in Mar. 2024 was 0.93.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. China National Medicines's Gross Margin % for the three months ended in Mar. 2024 was 7.03%.

China National Medicines COGS-to-Revenue Historical Data

The historical data trend for China National Medicines's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Medicines COGS-to-Revenue Chart

China National Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.91

0.92

China National Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.92	0.92	0.92	0.91	0.93

China National Medicines COGS-to-Revenue Calculation

China National Medicines's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	45704.777	/	49696.046
	=	0.92

China National Medicines's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	11270.056	/	12122.143
	=	0.93

China National Medicines (SHSE:600511) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

China National Medicines's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	11270.056 / 12122.143
	=	7.03 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

China National Medicines COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of China National Medicines's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Medicines (SHSE:600511) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077

Website

http://www.cncm.com.cn

China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.

China National Medicines (SHSE:600511) Headlines

No Headlines